UPCC 12824 Risk Reducing Salpingectomy with Delayed Oophorectomy as an Alternative to Risk-Reducing Salpingo-Oophorectomy in High-Risk Women to Assess the Safety of Prevention – US Cohort Study (WISP 2)
Recruiting
99 years or below
Female
Phase
N/A
1 Location
Brief description of study
The purpose of the study is to compare risk reducing salpingectomy with delayed oophorectomy to risk-reducing salpingo-oophorectomy in high risk-women.
Detailed description of study
To enroll, patients must meet eligibility criteria and sign ICF (no additional testing needed). After enrolling, patients fill out demographic and family history questionnaires. After surgery (RRSO or RRS/RRO), patients will have yearly follow-ups so the study team can collect information about the patient's health status.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Ovarian cancer prevention. BRCA1, BRCA2, BRIP1, RAD51C, RAD51D
-
Age: 99 years or below
-
Gender: Female
Inclusion
1.
Premenopausal women with a documented deleterious mutation in BRCA1, BRCA2,
BRIP1, RAD51C and/or RAD51D gene germline mutation
2. Age 25-40
years for BRCA1 mutation carriers, 25-45 years for BRCA2 and
30-50 years for BRIP1, RAD51C, RAD51D
3.
Childbearing completed or no longer requires fallopian tubes
4. Presence
of at least one fallopian tube
5.
Participants may have a personal history of non-ovarian malignancy
6. Informed
consent must be obtained and documented
1. Post menopausal status (natural menopause or due to
(cancer) treatment)
2. Wish for
second stage RRO within two years after RRS (if clear at enrollment)
3. Legally
incapable
4. Prior
bilateral salpingectomy
5. A
personal history of ovarian, fallopian tube or peritoneal cancer
6. Current
clinical signs, diagnosis or treatment for malignant disease
Updated on
08 Oct 2025.
Study ID: 24-0665
Find a site
,
Your Information has been sent successfully.
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or